The course Genomics for ecological, evolutionary and biodiversity studies: from DNA sequencing to data analysis is about to begin!!!
Don't forget to register before 4 November 2022

Read the details here

Magda Zanzottera added a new publication (29/11/2021)

Show me


  • No seminars planned for next week

Domenico Di Carlo
Project titleInvestigations on the ecological/epidemiological dynamics of the bacterial communities in the hospital environment
TutorClaudio Bandi
Co-tutor -
PhD cycleXXXIV
Thesis committee

Insert/modify publications Update


    ISI Journal articles
  • Bavaro, D., Di Carlo, D., Rossetti, B., Bruzzone, B., Vicenti, I., & Pontali, E. et al. (2020). Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA. Antiviral Therapy, 25(2), 61-71. doi: 10.3851/imp3349
  • Folgori, L., Di Carlo, D., Comandatore, F., Piazza, A., Witney, A., & Bresesti, I. et al. (2021). Antibiotic Susceptibility, Virulome, and Clinical Outcomes in European Infants with Bloodstream Infections Caused by Enterobacterales. Antibiotics, 10(6), 706. doi: 10.3390/antibiotics10060706
  • Pasala, A., Perini, M., Piazza, A., Panelli, S., Di Carlo, D., & Loretelli, C. et al. (2020). Repeatability and reproducibility of the wzi high resolution melting-based clustering analysis for Klebsiella pneumoniae typing. AMB Express, 10(1). doi: 10.1186/s13568-020-01164-7
  • Perini, M., Batisti Biffignandi, G., Di Carlo, D., Pasala, A., Piazza, A., & Panelli, S. et al. (2021). MeltingPlot, a user-friendly online tool for epidemiological investigation using High Resolution Melting data. BMC Bioinformatics, 22(1). doi: 10.1186/s12859-021-04020-y
  • Armenia, D., Di Carlo, D., Flandre, P., Bouba, Y., Borghi, V., & Forbici, F. et al. (2020). HIV MDR is still a relevant issue despite its dramatic drop over the years. Journal of Antimicrobial Chemotherapy, 75(5), 1301-1310
  • Armenia, D., Zaccarelli, M., Borghi, V., Gennari, W., Di Carlo, D., & Giannetti, A. et al. (2020). Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment.Journal of Clinical Virology, 104, 61-64
  • Carugati, M., Piazza, A., Peri, A., Cariani, L., Brilli, M., & Girelli, D. et al. (2020). Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature. BMC Infectious Diseases, 20(1). doi: 10.1186/s12879-020-05338-3
  • Colagrossi, L., Hermans, L., Salpini, R., Di Carlo, D., Pas, S., & Alvarez, M. et al. (2020). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.BMC Infectious Diseases, 18(1)
  • Perini, M., Piazza, A., Panelli, S., Di Carlo, D., Corbella, M., & Gona, F. et al. (2020). EasyPrimer: user-friendly tool for pan-PCR/HRM primers design. Development of an HRM protocol on wzi gene for fast Klebsiella pneumoniae typing.Scientific Reports, 10(1)
  • Salpini, R., Battisti, A., Piermatteo, L., Carioti, L., Anastasiou, O., & Gill, U. et al. (2020). Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. Emerging Microbes & Infections, 9(1), 928-939. doi: 10.1080/22221751.2020.1757998
  • Scutari, R., Alteri, C., Vicenti, I., Di Carlo, D., Zuccaro, V., & Incardona, F. et al. (2020). Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors. Journal Of Global Antimicrobial Resistance, 20, 163-169. doi: 10.1016/j.jgar.2019.07.015
  • Armenia, D., Di Carlo, D., Cozzi-Lepri, A., Calcagno, A., Borghi, V., & Gori, C. et al. (2019). Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. Antiviral Therapy. doi: 10.3851/imp3309
  • Bavaro, D., Di Carlo, D., Zuccalà, P., Bai, F., Incardona, F., & Battisti, A. et al. (2019). Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort. Infectious Diseases, 51(3), 234-239. doi: 10.1080/23744235.2018.1544423
  • Del Prete, R., Ronga, L., Addati, G., Magrone, R., Abbasciano, A., Di Carlo, D., & Santacroce, L. (2019). A Retrospective Study about the Impact of Switching from Nested PCR to Multiplex Real-Time PCR on the Distribution of the Human Papillomavirus (HPV) Genotypes. Medicina, 55(8), 418. doi: 10.3390/medicina55080418
  • Del Prete, R., Ronga, L., Magrone, R., Addati, G., Abbasciano, A., Di Carlo, D., & Miragliotta, G. (2019). Epidemiological evaluation of human papillomavirus genotypes and their associations in multiple infections. Epidemiology And Infection, 147. doi: 10.1017/s0950268818003539
  • Modica, S., Redi, D., Gagliardini, R., Giombini, E., Bezenchek, A., & Di Carlo, D. et al. (2019). Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study. Journal Of Antimicrobial Chemotherapy, 75(1), 194-199. doi: 10.1093/jac/dkz424
  • Salpini, R., Battisti, A., Colagrossi, L., Di Carlo, D., Fabeni, L., & Piermatteo, L. et al. (2019). A snapshot of virological presentation and outcome of immunosuppression‚Äźdriven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection. Journal Of Viral Hepatitis. doi: 10.1111/jvh.13101
  • Soulie, C., Santoro, M., Charpentier, C., Storto, A., Paraskevis, D., & Di Carlo, D. et al. (2018). Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients. Journal Of Antimicrobial Chemotherapy, 74(3), 614-617. doi: 10.1093/jac/dky464
  • Alteri, C., Fabeni, L., Scutari, R., Berno, G., Di Carlo, D., & Gori, C. et al. (2018). Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence. Scientific Reports, 8(1). doi: 10.1038/s41598-018-34058-7
  • Pouga, L., Santoro, M., Charpentier, C., Di Carlo, D., Romeo, I., & Artese, A. et al. (2018). New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T). Chemical Biology & Drug Design, 93(1), 50-59. doi: 10.1111/cbdd.13378
  • Santoro, M., Di Carlo, D., Armenia, D., Zaccarelli, M., Pinnetti, C., & Colafigli, M. et al. (2017). Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. Antiviral Therapy, 23(3), 249-257. doi: 10.3851/imp3197